Trademark/Service Mark Application, Principal Register
Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1478 (Rev 09/2006)
OMB No. 0651-0009 (Exp 02/28/2021)
Trademark/Service Mark Application, Principal Register
Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1478 (Rev 09/2006)
OMB No. 0651-0009 (Exp 02/28/2021)
Trademark/Service Mark Application, Principal Register
Serial Number:88597743
Filing Date:08/29/2019
To the Commissioner for Trademarks:
MARK: INNOVUS PHARMA (Standard Characters, see mark)
The literal element of the mark consists of INNOVUS PHARMA. The mark consists of standard characters, without claim to any particular font style, size, or color.
The applicant, Innovus Pharmaceuticals, Inc., a corporation of Nevada, having an address of
Legal
8845 Rehco Road
San Diego, California 92121
United States
858-249-7873(phone)
requests registration of the trademark/service mark identified above in the United States Patent and Trademark Office on the Principal Register established by the Act of July 5, 1946 (15 U.S.C.
Section 1051 et seq.), as amended, for the following:
International Class 005: Dietary and nutritional supplements; Dietary and nutritional supplements for boosting testosterone and immune system, increasing muscle growth and endurance, preventing
cachexia, increasing nitric oxide levels, increasing blood sugar levels, increasing blood flow, increasing sexual performance, increasing vision, weight loss, fat burning, prostate support, bladder
control, joint support, nerve support, increasing mental cognition and memory, providing omega 3 oils.
In International Class 005, the mark was first used by the applicant or the applicant's related company or licensee or predecessor in interest at least as early as 09/05/2013, and first used in
commerce at least as early as 09/05/2013, and is now in use in such commerce. The applicant is submitting one(or more) specimen(s) showing the mark as used in commerce on or in connection with any
item in the class of listed goods/services, consisting of a(n) The specimens consist of products sold and distributed by the Applicant.. Specimen File1 Specimen File2 Specimen File3
The applicant hereby appoints Randy Berholtz. Other appointed attorneys are Jake Siciliano. Randy Berholtz, is a member of the XX bar, admitted to the bar in XXXX, bar membership no. XXX, and
the attorney(s) is located at
Legal
8845 Rehco Road
San Diego, California 92121
United States
858-249-7873(phone)
rberholtz@innovuspharma.com (authorized).
Randy Berholtz submitted the following statement: The attorney of record is an active member in good standing of the bar of the highest court of a U.S. state, the District of Columbia, or any U.S.
Commonwealth or territory.
The applicant's current Correspondence Information:
Email Authorization: I authorize the USPTO to send email correspondence concerning the application to the applicant, the applicant's attorney, or the applicant's domestic representative at the
email address provided in this application. I understand that a valid email address must be maintained and that the applicant or the applicant's attorney must file the relevant subsequent
application-related submissions via the Trademark Electronic Application System (TEAS). Failure to do so will result in the loss of TEAS Reduced Fee status and a requirement to submit an additional
processing fee of $125 per international class of goods/services.
A fee payment in the amount of $275 has been submitted with the application, representing payment for 1 class(es).
Declaration
Declaration Signature
Signature: /Randy Berholtz/ Date: 08/29/2019
Signatory's Name: Randy Berholtz
Signatory's Position: EVP Corporate Development
Payment Sale Number: 88597743
Payment Accounting Date: 08/29/2019
Serial Number: 88597743
Internet Transmission Date: Thu Aug 29 12:19:37 EDT 2019
TEAS Stamp: USPTO/BAS-XXX.XX.XX.XXX-2019082912193725
7807-88597743-610156ae4a038aed1ced1bf7c0
f6409ee4b38d44d6a1837ce3750ac289fd3d6d7-
CC-19360969-20190829120335714095